Targeting multiple tyrosine kinase receptors with Dovitinib blocks invasion and the interaction between tumor cells and cancer-associated fibroblasts in breast cancer.

Dovitinib 通过靶向多种酪氨酸激酶受体，阻断乳腺癌的侵袭以及肿瘤细胞与癌相关成纤维细胞之间的相互作用